The relationship between the treatment course and prognosis of oligometastasis after esophageal squamous cell carcinoma resection

被引:1
作者
Matsumoto, Chihiro [1 ]
Iwatsuki, Masaaki [1 ]
Morinaga, Takeshi [1 ]
Horinouchi, Tomo [1 ]
Hara, Yoshihiro [1 ]
Baba, Yoshifumi [1 ]
Miyamoto, Yuji [1 ]
Yoshida, Naoya [1 ]
Baba, Hideo [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, 1-1-1 Honjo,Chuo Ku, Kumamoto 8608556, Japan
关键词
Esophageal squamous cell carcinoma; Prognosis; Oligorecurrence; CANCER; RECURRENCE; SURVIVAL; OUTCOMES;
D O I
10.1007/s00595-024-02803-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
PurposeThe concept of oligometastasis, which represents limited metastatic disease, has recently gained interest, accompanied by a more detailed classification. This study aims to investigate the relationship between the treatment course and prognosis in patients with a recurrence of esophageal squamous cell carcinoma (ESCC) after curative esophagectomy. Methods126 patients with ESCC recurrence after curative resection were enrolled in this study. Oligometastasis was defined as fewer than five recurrences in a single organ. Patients were classified as having oligometastatic recurrence (OLR) or polymetastatic recurrence (PLR). Patients were further classified into four subgroups according to lesion progression: persistent oligorecurrence (PER-OLR), converted polyrecurrence (CON-PLR), induced oligorecurrence (IND-OLR), and persistent polyrecurrence (PER-PLR). We analyzed the relationship between the recurrence patterns and prognosis according to the progression of oligometastatic lesions. ResultsOLR was identified in 58 (46%) of 126 patients with recurrence. Patients with OLR had a significantly better prognosis than those with PLR (P < 0.0001). A further subgroup analysis revealed that patients who underwent IND-OLR had a similar prognosis to those who underwent PER-OLR. ConclusionsThis study suggests that OLR is a prognostic factor after recurrence following resection of ESCC and that PLR can be converted to OLR by therapeutic intervention to achieve a long-term survival.
引用
收藏
页码:927 / 934
页数:8
相关论文
共 29 条
[1]   Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road [J].
Depypere, L. ;
Lerut, T. ;
Moons, J. ;
Coosemans, W. ;
Decker, G. ;
Van Veer, H. ;
De Leyn, P. ;
Nafteux, P. .
DISEASES OF THE ESOPHAGUS, 2017, 30 (01) :1-8
[2]   Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma [J].
Doki, Y. ;
Ajani, J. A. ;
Kato, K. ;
Xu, J. ;
Wyrwicz, L. ;
Motoyama, S. ;
Ogata, T. ;
Kawakami, H. ;
Hsu, C. -H. ;
Adenis, A. ;
El Hajbi, F. ;
Di Bartolomeo, M. ;
Braghiroli, M. I. ;
Holtved, E. ;
Ostoich, S. A. ;
Kim, H. R. ;
Ueno, M. ;
Mansoor, W. ;
Yang, W. -C. ;
Liu, T. ;
Bridgewater, J. ;
Makino, T. ;
Xynos, I. ;
Liu, X. ;
Lei, M. ;
Kondo, K. ;
Patel, A. ;
Gricar, J. ;
Chau, I. ;
Kitagawa, Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05) :449-462
[3]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247
[4]   Predictors of Survival After Treatment of Oligometastases After Esophagectomy [J].
Ghaly, Galal ;
Harrison, Sebron ;
Kamel, Mohamed K. ;
Rahouma, Mohamed ;
Nasar, Abu ;
Port, Jeffrey L. ;
Stiles, Brendon M. ;
Altorki, Nasser K. .
ANNALS OF THORACIC SURGERY, 2018, 105 (02) :357-362
[5]   Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation [J].
Guckenberger, Matthias ;
Lievens, Yolande ;
Bouma, Angelique B. ;
Collette, Laurence ;
Dekker, Andre ;
deSouza, Nandita M. ;
Dingemans, Anne-Marie C. ;
Fournier, Beatrice ;
Hurkmans, Coen ;
Lecouvet, Frederic E. ;
Meattini, Icro ;
Romero, Alejandra Mendez ;
Ricardi, Umberto ;
Russell, Nicola S. ;
Schanne, Daniel H. ;
Scorsetti, Marta ;
Tombal, Bertrand ;
Verellen, Dirk ;
Verfaillie, Christine ;
Ost, Piet .
LANCET ONCOLOGY, 2020, 21 (01) :E18-E28
[6]   Treatment Outcomes and Prognostic Factors After Recurrence of Esophageal Squamous Cell carcinoma [J].
Hamai, Yoichi ;
Hihara, Jun ;
Emi, Manabu ;
Furukawa, Takaoki ;
Ibuki, Yuta ;
Yamakita, Ichiko ;
Kurokawa, Tomoaki ;
Okada, Morihito .
WORLD JOURNAL OF SURGERY, 2018, 42 (07) :2190-2198
[7]   OLIGOMETASTASES [J].
HELLMAN, S ;
WEICHSELBAUM, RR .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :8-10
[8]   Detection and management of oligometastatic disease in oesophageal cancer and identification of prognostic factors: A systematic review [J].
Jamel, Sara ;
Tukanova, Karina ;
Markar, Sheraz .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (09) :741-749
[9]   Japanese Classification of Esophageal Cancer, 11th Edition: part I [J].
Japan Esophageal Society .
ESOPHAGUS, 2017, 14 (01) :1-36
[10]   Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study [J].
Jingu, Keiichi ;
Matsushita, Haruo ;
Takeda, Ken ;
Umezawa, Rei ;
Takahashi, Chiaki ;
Sugawara, Toshiyuki ;
Kubozono, Masaki ;
Abe, Keiko ;
Tanabe, Takaya ;
Shirata, Yuko ;
Yamamoto, Takaya ;
Ishikawa, Youjirou ;
Nemoto, Kenji .
BMC CANCER, 2012, 12